Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frits van Rhee

Showing results (41-50 of 274) with videos related to

Pageof 28
Sort By:
Critical Reviews in Oncogenesis|June 19, 2014
Clinical grade purification and expansion of natural killer cellsNatalia Lapteva, Susann M Szmania, Frits van Rhee, et al.
Haematologica|June 12, 2025
Altered mesenchymal and endothelial subsets in interstitial bone marrow and focal lesions in myeloma patients and SCID-hu miceWen Ling, Maurizio Zangari, Frits Van Rhee, et al.
Clinical Advances in Hematology & Oncology : H&O|September 25, 2010
Castleman disease in the 21st century: an update on diagnosis, assessment, and therapyFrits van Rhee, Katie Stone, Susann Szmania, et al.
JAMA Network Open|April 20, 2022
Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor-T Cell Therapy for Hematological Malignant NeoplasmsSamer Al Hadidi, Carolina Schinke, Sharmilan Thanendrarajan, et al.
Cancer Treatment Reviews|April 22, 2017
Immunologic approaches for the treatment of multiple myelomaLeo Rasche, Niels Weinhold, Gareth J Morgan, et al.
JAMA Dermatology|February 22, 2013
Eruptive cherry hemangiomatosis associated with multicentric Castleman disease: a case report and diagnostic clueDavid C Fajgenbaum, David Fajgenbaum, Misha Rosenbach, et al.
Blood|October 9, 2014
Curing myeloma at last: defining criteria and providing the evidenceBart Barlogie, Alan Mitchell, Frits van Rhee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Race-Dependent Differences in Risk, Genomics, and Epstein-Barr Virus Exposure in Monoclonal Gammopathies: Results of SWOG S0120Madhav V Dhodapkar, Rachael Sexton, Antje Hoering, et al.
European Journal of Haematology|July 9, 2021
Combinatorial treatment for unresectable unicentric Castleman diseaseMeera Mohan, James C Meek, Mary Elizabeth Meek, et al.
Ejhaem|September 2, 2022
Global public awareness of Castleman disease and TAFRO syndrome between 2015 and 2021: A Google Trends analysisYoshito Nishimura, Midori Filiz Nishimura, David C Fajgenbaum, et al.
Pageof 28

Showing results (41-50 of 274) with videos related to

Sort By:
Pageof 28
Critical Reviews in Oncogenesis|June 19, 2014
Clinical grade purification and expansion of natural killer cellsNatalia Lapteva, Susann M Szmania, Frits van Rhee, et al.
Haematologica|June 12, 2025
Altered mesenchymal and endothelial subsets in interstitial bone marrow and focal lesions in myeloma patients and SCID-hu miceWen Ling, Maurizio Zangari, Frits Van Rhee, et al.
Clinical Advances in Hematology & Oncology : H&O|September 25, 2010
Castleman disease in the 21st century: an update on diagnosis, assessment, and therapyFrits van Rhee, Katie Stone, Susann Szmania, et al.
JAMA Network Open|April 20, 2022
Enrollment of Black Participants in Pivotal Clinical Trials Supporting US Food and Drug Administration Approval of Chimeric Antigen Receptor-T Cell Therapy for Hematological Malignant NeoplasmsSamer Al Hadidi, Carolina Schinke, Sharmilan Thanendrarajan, et al.
Cancer Treatment Reviews|April 22, 2017
Immunologic approaches for the treatment of multiple myelomaLeo Rasche, Niels Weinhold, Gareth J Morgan, et al.
JAMA Dermatology|February 22, 2013
Eruptive cherry hemangiomatosis associated with multicentric Castleman disease: a case report and diagnostic clueDavid C Fajgenbaum, David Fajgenbaum, Misha Rosenbach, et al.
Blood|October 9, 2014
Curing myeloma at last: defining criteria and providing the evidenceBart Barlogie, Alan Mitchell, Frits van Rhee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Race-Dependent Differences in Risk, Genomics, and Epstein-Barr Virus Exposure in Monoclonal Gammopathies: Results of SWOG S0120Madhav V Dhodapkar, Rachael Sexton, Antje Hoering, et al.
European Journal of Haematology|July 9, 2021
Combinatorial treatment for unresectable unicentric Castleman diseaseMeera Mohan, James C Meek, Mary Elizabeth Meek, et al.
Ejhaem|September 2, 2022
Global public awareness of Castleman disease and TAFRO syndrome between 2015 and 2021: A Google Trends analysisYoshito Nishimura, Midori Filiz Nishimura, David C Fajgenbaum, et al.
Pageof 28